510(k) Report

510(k) · Cleared

Recalled · Class III · 2014

Gen-Probe Aptima Combo 2 Assay

K003395510(k) TraditionalCleared May 21, 2001201-day reviewClass II21 CFR 866.3390Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Gen-Probe, Inc. · LSL Dna-Reagents, Neisseria

Cleared on May 21, 2001 after a 201-day review. FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known. 42 later devices descend from it. It has been recalled once.

Decided
May 21, 2001
Review
201 days
Class
Class II
Product code
LSL
Recalls
1
Predicates
0

42 later devices descend from it, 4 citing it directly.

Descendants, by year cleared 2005: 1 descendant cleared2008: 3 descendants cleared2003: 1 descendant cleared2012: 2 descendants cleared2010: 1 descendant cleared2014: 4 descendants cleared2009: 5 descendants cleared2016: 2 descendants cleared2019: 3 descendants cleared2018: 2 descendants cleared2021: 3 descendants cleared2015: 1 descendant cleared2022: 2 descendants cleared2013: 1 descendant cleared2017: 1 descendant cleared2020: 1 descendant cleared2023: 2 descendants cleared2025: 4 descendants cleared2026: 3 descendants cleared200020052010201520202025
  1. This deviceK003395 Gen-Probe Aptima Combo 2 AssayGen-Probe, Inc. · 2001
  2. Descendant · cites it directly · 26 of its ownK081825 BD Probetec Neisseria Gonorrhoeae (GC) Q Amplified Dna AssayBecton, Dickinson & CO · 2008 · Recalled
  3. Descendant · cites it directly · 21 of its ownK043224 Gen-Probe Aptima Combo 2 AssayGen-Probe, Inc. · 2005
  4. Descendant · 2 generations on · 13 of its ownK091724 BD Probetec Chlamydia Trachomatis (CT) Q Amplified Dna AssayBecton, Dickinson & CO · 2009
  5. Descendant · 2 generations on · 13 of its ownK091730 BD Probetec Neisseria Gonorrhoeae (GC) QX Amplified Dna AssayBecton, Dickinson & CO · 2009 · Recalled
  6. Descendant · 2 generations on · 11 of its ownK092704 Abbott Realtime CT/NG and Abbott Multi-Collect Specimen Collection…Abbott Molecular, Inc. · 2010 · Recalled

Showing 5 of 42 descendants. See all descendants

Descendants cleared per year

2003: 12005: 12008: 32009: 52010: 12012: 22013: 12014: 42015: 12016: 22017: 12018: 22019: 32020: 12021: 32022: 22023: 22025: 42026: 3
2003high 5 (2009) · low 0 (2004)2026

Most influential descendants

Showing 5 of 42 · See all
  • K081825BD Probetec Neisseria Gonorrhoeae (GC) Q Amplified Dna AssayBecton, Dickinson & CO · 2008 · cites it directly26descendants
  • K043224Gen-Probe Aptima Combo 2 AssayGen-Probe, Inc. · 2005 · cites it directly21descendants
  • K091724BD Probetec Chlamydia Trachomatis (CT) Q Amplified Dna AssayBecton, Dickinson & CO · 2009 · 2 generations on13descendants
  • K091730BD Probetec Neisseria Gonorrhoeae (GC) QX Amplified Dna AssayBecton, Dickinson & CO · 2009 · 2 generations on13descendants
  • K092704Abbott Realtime CT/NG and Abbott Multi-Collect Specimen Collection Kit, Models 8L07-91…Abbott Molecular, Inc. · 2010 · 2 generations on11descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K003395Gen-Probe Aptima Combo 2 AssayGen-Probe, Inc.2001—
+1K081825BD Probetec Neisseria Gonorrhoeae (GC) Q Amplified Dna AssayBecton, Dickinson & CO20081
+1K043224Gen-Probe Aptima Combo 2 AssayGen-Probe, Inc.2005—
+2K091724BD Probetec Chlamydia Trachomatis (CT) Q Amplified Dna AssayBecton, Dickinson & CO2009—
+2K091730BD Probetec Neisseria Gonorrhoeae (GC) QX Amplified Dna AssayBecton, Dickinson & CO20091
+2K092704Abbott Realtime CT/NG and Abbott Multi-Collect Specimen Collection Kit, Models…Abbott Molecular, Inc.20101

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200310
200510
200830
200950
201010
201220
201310
201440
201510
201620
201710
201820
201930
202010
202130
202220
202320
202540
202630
FIG. 1 — Lineage of K003395, 2001–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LSL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LSL device

  1. #1 K231329 Aptima Neisseria gonorrhoeae Assayscore 6.7 · 1 generation · no Class I recall
Get a 510(k) Report

What was it cleared against?

FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known.

What descends from it? (42)

See all 42

4 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K081825BD Probetec Neisseria Gonorrhoeae (GC) Q Amplified Dna AssayBecton, Dickinson & CO200826
K043224Gen-Probe Aptima Combo 2 AssayGen-Probe, Inc.200521
K081824BD Probetec Chlamydia Trachomatis (CT) Q Amplified Dna AssayBecton, Dickinson & CO20089
K032554Gen-Probe Aptima Combo 2 AssayGen-Probe, Inc.20031

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Apr 17, 2014Class IIIZ-1793-2014Labeling mix-upsIncorrect labeling was used on each pouch of the affected lots of APTIMA Urine Specimen Collection Kits. The outer box of the kits are identified correctly as "APTIMA Urine Collection Kits"; however, the inner pouches are incorrectly…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K081825 (Becton, Dickinson & CO, 2008) has gone furthest, with 26 descendants of its own.

How does its category compare?

All LSL devices

LSL Dna-Reagents, Neisseria: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LSL

1in 2024

2007: 22008: 12009: 32012: 22013: 22014: 32017: 12018: 32024: 1
2007high 3 (2009) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LSL

90in 2018

2009: 62 days median2014: 86 days median2018: 90 days median
2007high 90 (2018) · low 62 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LSL

1in 2017

2017: 1
2007high 1 (2017) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LSL

41in 2025

2009: 42010: 12011: 12013: 12014: 42015: 62016: 62017: 102018: 72019: 142020: 32021: 42022: 112023: 192024: 172025: 41
2007high 41 (2025) · low 0 (2007)2025

MAUDE reports naming product code LSL, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20081—00
200936204
20100—01
20110—01
20122—00
20132—01
201438604
20150—06
20160—06
20171—110
201839007
20190—014
20200—03
20210—04
20220—011
20230—019
20241—017
20250—041
20260—0—
Cite this page

510(k) Report. “K003395: Gen-Probe Aptima Combo 2 Assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K003395

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026